Publisher : Chinese Pharmacopoeia Commission
Published Date : 8/2011
Language : English
ISBN/ISSN : 9787506750134 / 9787506750110 / 9787506750059
Pages : 3382
Weight : 9.20kg
Availability : Usually ship within one week
Book Type : Reference
Remarks : A Set of 3 Volumes
Estimated Shipping Time

This edition of the Pharmacopoeia of the People’s Republic of China ( known as Chinese Pharmacopoeia 2010 or in abbreviation as ChP 2010 ) has been prepared in accordance with the principles and requirements recommended by the Ninth Pharmacopoeia Commission and accomplished with the effort made by Commission members and its Secretariat and with collaborated support of relevant institutions and organizations. The draft text has been reviewed and approved by the Executive Committee of the Pharmacopoeia Commission. This is the ninth edition of Chinese Pharmacopoeia since the founding of the People’s Republic of China.

Chinese Pharmacopoeia 2010 is published in three volumes, and contains up to 4567 monographs with 1386 new admissions. In Volume I, it contains monographs of Chinese crude drugs and the prepared slices. Vegetable oil/fat and its extract, the patented Chinese traditional medicines, single ingredient of Chinese crude drug preparations etc. it has 2165 monographs with 1019 new admissions (439 articles of the prepared slice) and 634 revised; Volume II deals with monographs of chemical drugs, antibiotics, biochemical preparations, radiopharmaceuticals and excipients for pharmaceutical use, contains 2271 monographs with 330 new admissions and 1500 revised; Volume III contains biological products, has 131 monographs with 37 new admissions and 94 revised.

The number of articles in Appendices of this edition is much varied. There are 14 new admissions and 47 revised, in Volume I. There are 15 new admissions and 69 revised in Appendices of Volume II. There are 18 new admissions and 39 revised in Appendices of Volume III. Appropriate monographs common to all three volumes are presented in each volume respectively in a harmonized and unified form.

The main changes in the revision of this edition of Chinese Pharmacopoeia are as follows:

• Monographs adopted in this edition of Chinese Pharmacopoeia are significantly increased comparing with previous editions.
• Applications of contemporary techniques of analysis is further enhanced and stressed in this edition.
• The guarantee of pharmaceutical safety is further strengthened.
• The controllability and effectiveness of drug quality are further improved.
• The contents of drug standards are scientific and normative.
• Encouraging technical innovation, actively participating in international coordinatioin.